EDGAR Filing Documents for 0001654954-16-002861

Form 8-K - Current report:

SEC Accession No. 0001654954-16-002861

Filing Date

2016-10-14

Accepted

2016-10-14 16:30:07

Documents

Period of Report

2016-10-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	azurrx8k_oct112016.htm	8-K	22132
2	UNDERWRITING AGREEMENT	ex1-1.htm	EX-1.1	421203
3	PRESS RELEASE	ex99-1.htm	EX-99.1	10162
4	IMAGE	azurrx_logo.jpg	GRAPHIC	17637
	Complete submission text file	0001654954-16-002861.txt		479162

Mailing Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 217 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 161937340
SIC: 2834 Pharmaceutical Preparations